HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hiroaki Kodama Selected Research
Hiroaki Kodama Research Topics
Disease
23
Neoplasms (Cancer)
05/2024 - 01/2010
14
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 01/2021
6
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2024 - 12/2021
5
Neoplasm Metastasis (Metastasis)
12/2021 - 01/2016
4
Neuroblastoma
01/2020 - 01/2019
3
Cachexia
05/2024 - 01/2022
3
Carcinoma (Carcinomatosis)
01/2024 - 12/2006
3
Lung Neoplasms (Lung Cancer)
01/2024 - 10/2020
3
Pneumonia (Pneumonitis)
04/2022 - 02/2020
2
Colorectal Neoplasms (Colorectal Cancer)
05/2024 - 06/2019
2
Body Weight (Weight, Body)
05/2024 - 08/2022
2
Febrile Neutropenia
01/2024 - 12/2023
2
Inflammation (Inflammations)
01/2022 - 01/2021
2
Carcinogenesis
01/2021 - 06/2014
2
Melanoma (Melanoma, Malignant)
01/2020 - 01/2016
2
Glioblastoma (Glioblastoma Multiforme)
06/2019 - 01/2019
2
Stillbirth
11/2012 - 08/2012
1
Weight Gain
05/2024
1
Type 2 Diabetes Mellitus (MODY)
05/2024
1
Neutropenia
01/2024
1
Radiation Pneumonitis
03/2023
1
Weight Loss (Weight Reduction)
02/2022
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1
Lung Diseases (Lung Disease)
02/2020
1
Breast Neoplasms (Breast Cancer)
01/2020
1
Pancreatic Neoplasms (Pancreatic Cancer)
08/2019
1
Colitis-Associated Neoplasms
06/2019
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2019
1
Polyps
06/2019
1
Colonic Neoplasms (Colon Cancer)
06/2019
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016
1
Mitochondrial Diseases (Mitochondrial Disease)
01/2016
1
Wounds and Injuries (Trauma)
07/2011
1
Burkitt Lymphoma (Burkitt's Lymphoma)
03/2010
1
Hypoxia (Hypoxemia)
12/2006
Drug/Important Bio-Agent (IBA)
9
Immune Checkpoint Inhibitors
IBA
01/2024 - 02/2020
8
Peptides (Polypeptides)
IBA
01/2021 - 01/2016
7
Tenascin
IBA
01/2021 - 06/2014
5
Proteins (Proteins, Gene)
FDA Link
06/2019 - 08/2002
4
Tyrosine Kinase Inhibitors
IBA
12/2021 - 01/2021
4
ErbB Receptors (EGF Receptor)
IBA
12/2021 - 01/2021
4
Fibronectins (Fibronectin)
IBA
01/2020 - 03/2010
4
Integrins
IBA
06/2019 - 06/2014
3
Ligands
IBA
01/2023 - 08/2014
3
durvalumab
IBA
04/2022 - 04/2021
3
B7-H1 Antigen
IBA
02/2022 - 01/2021
3
pembrolizumab
IBA
01/2022 - 10/2020
3
Tretinoin (Retinoic Acid)
FDA Link
Generic
01/2020 - 01/2019
3
N-Myc Proto-Oncogene Protein
IBA
01/2020 - 01/2019
3
Oncogene Proteins (Oncogene Protein)
IBA
08/2019 - 01/2019
2
Docetaxel (Taxotere)
FDA Link
01/2024 - 01/2023
2
pegfilgrastim (Neulasta)
FDA Link
01/2024 - 12/2023
2
Ramucirumab
IBA
01/2024 - 01/2023
2
Platinum
IBA
01/2023 - 10/2020
2
osimertinib
IBA
11/2021 - 01/2021
2
Platelet-Derived Growth Factor
IBA
06/2019 - 01/2019
2
Transcription Factors (Transcription Factor)
IBA
01/2019 - 08/2002
1
anamorelin
IBA
05/2024
1
Glucose (Dextrose)
FDA Link
Generic
05/2024
1
Ghrelin Receptors
IBA
05/2024
1
Hemoglobins (Hemoglobin)
IBA
05/2024
1
amrubicin
IBA
12/2023
1
Carboplatin (JM8)
FDA Link
Generic
01/2023
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2023
1
Etoposide (VP 16)
FDA Link
Generic
01/2023
1
Therapeutic Uses
IBA
01/2022
1
Angiogenesis Inhibitors
IBA
11/2021
1
Biomarkers (Surrogate Marker)
IBA
04/2021
1
Heparin-binding EGF-like Growth Factor (HB-EGF)
IBA
01/2021
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
02/2020
1
Matrix Metalloproteinases (MMPs)
IBA
01/2020
1
3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acid
IBA
07/2019
1
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
06/2019
1
Solutions
IBA
01/2019
1
Temozolomide (Temodar)
FDA Link
Generic
01/2019
1
Methyltransferases
IBA
01/2019
1
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2016
1
Nitrogen
IBA
01/2016
1
Aclarubicin
IBA
01/2016
1
Apoptosis Regulatory Proteins
IBA
01/2016
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2016
1
Quinoxalines
IBA
08/2014
1
Luciferases
IBA
07/2011
1
Syndecan-4
IBA
03/2010
1
Suspensions
IBA
03/2010
1
Integrin alpha4beta1 (VLA-4)
IBA
03/2010
1
Fibronectin Receptors
IBA
03/2010
1
Histone Deacetylases (Histone Deacetylase)
IBA
01/2010
1
Histamine (Histamine Dihydrochloride)
FDA Link
12/2006
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2006
1
N(4)-methoxy-5-methylcytosine
IBA
12/2006
Therapy/Procedure
15
Drug Therapy (Chemotherapy)
01/2024 - 01/2016
11
Therapeutics
01/2024 - 08/2014
3
Oral Administration
08/2022 - 08/2012
3
Chemoradiotherapy
01/2022 - 04/2021
3
Immunotherapy
01/2022 - 01/2021
1
Radiotherapy
03/2023
1
Aftercare (After-Treatment)
11/2021
1
Palliative Care (Palliative Therapy)
02/2020
1
Transplantation
12/2006